(S (NP (NNP Breast) (NNP Cancer)) (VP (VBZ is) (NP (DT a) (JJ major) (NN cause)) (PP (IN of) (NP (NN death))) (ADVP (NN worldwide)) (PP (IN among) (NP (NNS women)))) (. .))
(S (NP (NP (NNP Hematoxylin) (CC and) (NNP Eosin) (PRN (-LRB- -LRB-) (NP (NNP H) (CC &) (NNP E)) (-RRB- -RRB-)) (VBD stained) (JJ breast) (NN tissue) (NNS samples)) (PP (IN from) (NP (NNS biopsies)))) (VP (VBP are) (VP (VBN observed) (PP (IN under) (NP (NNS microscopes))) (PP (IN for) (NP (NP (DT the) (JJ primary) (NN diagnosis)) (PP (IN of) (NP (NN breast) (NN cancer))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN paper))) (, ,) (NP (PRP we)) (VP (VBP propose) (NP (NP (DT a) (JJ deep) (JJ learning-based) (NN method)) (PP (IN for) (NP (NP (NN classification)) (PP (IN of) (NP (NP (ADJP (NNP H) (CC &) (NNP E) (VBD stained)) (JJS breast) (NN tissue) (NNS images)) (VP (VBN released) (PP (IN for) (NP (NNP BACH) (NN challenge) (CD 2018)))))))) (PP (IN by) (S (VP (JJ fine-tuning) (NP (NP (NNP Inception-v3) (JJ convolutional) (JJ neural) (NN network)) (PRN (-LRB- -LRB-) (NP (NNP CNN)) (-RRB- -RRB-)))))) (VP (VBN proposed) (PP (IN by) (NP (NNP Szegedy) (CC et) (NN al)))))) (. .))
(S (NP (DT These) (NNS images)) (VP (VBP are) (S (VP (TO to) (VP (VB be) (VP (VBN classified) (PP (IN into) (NP (NP (CD four) (NNS classes)) (ADVP (RB namely)) (, ,) (NP (NP (NN i) (-RRB- -RRB-) (NP (JJ normal) (NN tissue))) (, ,) (NP (PRN (NN ii) (-RRB- -RRB-)) (NP (NN benign) (NN tumor))) (, ,) (PRN (NN iii) (-RRB- -RRB-)) (NP (NN in-situ) (NN carcinoma)) (CC and) (ADJP (NN iv) (-RRB- -RRB-) (NP (JJ invasive) (NN carcinoma))))))))))) (. .))
(S (NP (PRP$ Our) (NN strategy)) (VP (VBZ is) (S (VP (TO to) (VP (VB extract) (NP (NNS patches)) (PP (VBN based) (PP (IN on) (NP (NP (NP (JJ nuclei) (NN density)) (PP (RB instead) (IN of) (NP (NN random) (CC or) (NN grid) (NN sampling)))) (, ,) (PP (IN along) (PP (IN with) (NP (NP (NN rejection)) (PP (IN of) (NP (NP (NNS patches)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (RB not) (ADJP (JJ rich) (PP (IN in) (NP (NP (JJ nuclei) (PRN (-LRB- -LRB-) (JJ non-epithelial) (-RRB- -RRB-)) (NNS regions)) (PP (IN for) (NP (NN training) (CC and) (NN testing))))))))))))))))))))) (. .))
(S (NP (NP (DT Every) (NN patch)) (PRN (-LRB- -LRB-) (NP (JJ nuclei-dense) (NN region)) (-RRB- -RRB-)) (PP (IN in) (NP (DT an) (NN image)))) (VP (VBZ is) (VP (VBN classified) (PP (IN in) (NP (NP (CD one)) (PP (IN of) (NP (DT the) (CD four) (ADJP (IN above) (VBN mentioned)) (NNS categories))))))) (. .))
(S (NP (NP (DT The) (NN class)) (PP (IN of) (NP (DT the) (JJ entire) (NN image)))) (VP (VBZ is) (VP (VBN determined) (S (VP (VBG using) (NP (NP (NN majority) (NN voting)) (PP (IN over) (NP (DT the) (JJ nuclear) (NNS classes)))))))) (. .))
(S (NP (PRP We)) (VP (VBD obtained) (NP (NP (NP (DT an) (JJ average) (ADJP (CD four) (NN class)) (NN accuracy)) (PP (IN of) (NP (CD 85) (NN %)))) (CC and) (NP (NP (DT an) (JJ average) (PRN (ADJP (CD two) (NN class)) (PRN (-LRB- -LRB-) (ADJP (JJ non-cancer) (PP (FW vs.) (NP (NN carcinoma)))) (-RRB- -RRB-))) (NN accuracy)) (PP (IN of) (NP (CD 93) (NN %)))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ improves) (PP (IN upon) (NP (NP (DT a) (JJ previous) (NN benchmark)) (PP (IN by) (NP (NNP Araujo) (CC et) (NN al)))))))))) (. .))
